US20110004295A1 - Implant valve for implantation in a blood vessel - Google Patents
Implant valve for implantation in a blood vessel Download PDFInfo
- Publication number
- US20110004295A1 US20110004295A1 US12/807,405 US80740510A US2011004295A1 US 20110004295 A1 US20110004295 A1 US 20110004295A1 US 80740510 A US80740510 A US 80740510A US 2011004295 A1 US2011004295 A1 US 2011004295A1
- Authority
- US
- United States
- Prior art keywords
- tube
- support
- casing
- blood vessel
- implantation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/24—Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body
- A61F2/2475—Venous valves
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/24—Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body
- A61F2/2412—Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body with soft flexible valve members, e.g. tissue valves shaped like natural valves
- A61F2/2418—Scaffolds therefor, e.g. support stents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/24—Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body
- A61F2/2427—Devices for manipulating or deploying heart valves during implantation
- A61F2/243—Deployment by mechanical expansion
- A61F2/2433—Deployment by mechanical expansion using balloon catheter
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2230/00—Geometry of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2230/0002—Two-dimensional shapes, e.g. cross-sections
- A61F2230/0028—Shapes in the form of latin or greek characters
- A61F2230/0054—V-shaped
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S623/00—Prosthesis, i.e. artificial body members, parts thereof, or aids and accessories therefor
- Y10S623/901—Method of manufacturing prosthetic device
Definitions
- the invention relates to an implant valve for implantation in a blood vessel.
- Such implant valves are known and are applied for regulating the blood circulation through a vascular system, such as the human vascular system.
- the vascular system in particular the venous vascular system in legs and arms, is, at certain locations, provided with bag-shaped valves, also called “cusps”.
- the function of the valves is to impede the blood flowing against the direction of the blood circulation through the vascular system. In particular, this function is important in the period of relatively low blood pressure in the vascular system, occurring between systoles of the heart.
- valves in the vessels of the vascular system do not close properly, so that blood can flow through the valves against the blood circulation. This problem especially occurs when the valves are damaged as a result of blood clots (thrombosis). Further, the closing action of the valves or cusps can be lost due to the diameter of veins increasing, for instance when the elasticity of the veins decreases.
- implant valves with artificially formed bag-shaped valves in the veins.
- An implant valve with an expandable support provided with bag-shaped valves and a method for percutaneously fitting such an implant valve in a vein are known from NL 1004827.
- a drawback of the known implant valve is that it, in itself, increases the chance of clotting of blood or thrombosis considerably.
- the known valve body is provided with a relatively rough and irregular surface, which increases the chance of clotting through adhesion.
- the flow resistance in the direction of the blood circulation is not optimally low.
- valve body specific material is a problem.
- the implant valve because of the relatively complex construction of the implant valve, it has proved to be a problem to design it with a sufficiently small diameter to move it to body extremities such as forearms or lower legs.
- the object of the invention is an implant valve which does not have the above-mentioned drawbacks.
- the invention provides an implant valve for implantation in a blood vessel, comprising a flexible tube and a hollow, substantially cylindrical support with a casing which is expandable in diameter from an initial position into an implantation position, the support extending over a part of the length of the tube substantially coaxially along the inner wall of the tube and the casing of the support cooperating with the inner wall of the tube such that, in the implantation position of the support, a first part of the tube can be formed to be a rigid shell which can be clamped substantially coaxially along the inner wall of a blood vessel, while a second, axially contiguous part of the tube can form a flexible, tubular valve body which can extend substantially free in the blood vessel.
- the valve has a simple construction, so that it can be relatively easily manufactured with a small diameter.
- the flexible tube of the valve can relatively easily be designed from body specific material.
- the valve has a relatively low flow resistance, in particular when a substantially cylindrical flexible tube is applied, and when blood flows through it in the direction of the blood circulation from the rigid, tubular part, while circulation in the opposite direction through deformation of the tubular flexible valve body is effectively counteracted. Further, it is achieved that the chance of blood clotting as a result of the valve can be considerably reduced.
- the invention further relates to a method for implanting an implant valve and to a method for manufacturing an implant valve.
- valve an implant valve
- the invention will be further elucidated on the basis of an exemplary embodiment, represented in a drawing.
- FIG. 1 shows a schematic, partly sectional perspective view of a first embodiment of the implant valve
- FIG. 1A shows a schematic perspective view of a support in initial position
- FIG. 1B shows a schematic perspective view of a support in implantation position
- FIG. 2A shows a schematic perspective view of the implant valve of FIG. 1 in implanted condition during a systole of the muscle pump;
- FIG. 2B shows the implant valve of FIG. 2A in the diastolic phase between two systoles of the muscle pump;
- FIG. 3 shows a schematic cross section of a second embodiment of the implant valve
- FIG. 4 shows a schematic representation of the implantation of the implant valve with the aid of a transport device.
- FIGS. 1 and 2 there is shown an implant valve 1 for implantation in a blood vessel 2 .
- the implant valve 1 comprises a flexible tube 3 and a hollow, substantially cylindrical support 4 .
- the tube 3 is manufactured from biocompatible material, preferably body specific material.
- the support 4 has a casing 5 , expandable in diameter from an initial position I to an implantation position II.
- FIG. 1A shows the support 4 in the initial position I
- FIG. 1B shows the support 4 in the implantation position II. From the initial position I, the support 4 expands over its entire length l in radial direction in relation to its longitudinal axis A, such that the diameter of the casing 5 of the support 4 increases from a first value D 1 to a greater value D 2 . It is noted that, normally, the length l then decreases to a value l′.
- the casing 5 of support 4 is preferably built up from an interlacement of two cylindrically interwoven, zigzagging, biocompatible metal wires 6 .
- the interlacement can be designed to be pushed, with the aid of a balloon catheter, from the initial position I into the implantation position II (Balloon extendable type), but can also be designed from memory metal which, upon expansion, unfolds itself from the initial condition into the implantation condition II (Self expandable type).
- Such supports are usually referred to as “stents”, and, since they are generally known, will not be further elucidated here.
- the support 4 extends over a part l of the length L of the tube 3 .
- the casing 5 of the support 4 is connected to the inner wall 3 A of the tube 3 , for instance in that the wires 6 of the casing 5 of the support 4 are sewn to the tube 3 , such that the inner wall 3 A, in the implantation position I, loosely envelops the outer casing surface 5 A of the support 4 .
- the outer surface 5 A of the casing 5 cooperates with the inner wall 3 A of the tube 3 such that, in the implantation position, the inner wall 3 A is pulled taut by the outer surface 5 A of the support to form a rigid shell 9 .
- the rigid shell 9 extends over a first part l of the length L of the tube 3 .
- a second part of the tube 3 contiguous thereto in axial direction A is not supported by the support 4 and forms a flexible, tubular valve body 10 .
- the rigid shell 9 In implanted condition in a blood vessel 2 , the rigid shell 9 extends substantially coaxially along the inner wall 2 A of the blood vessel, and the outer wall 3 B of the tube 3 is clamped by the support 4 in implantation position II, in a tubular shape, against the inner wall 2 A of the blood vessel 2 .
- the second part of the tube 3 contiguous thereto in axial direction forms a flexible, tubular valve body 10 extending over a part k of the length L of the tube, extending substantially clear in the blood vessel 2 .
- the outer wall 3 B of the tube 3 is then substantially clear of the inner wall 2 A of the blood vessel 2 .
- blood can pass in the direction of the arrow 11 in the direction of the blood circulation through the implant valve 1 , for instance upon a systole of the muscle pump.
- the inflow opening 12 of the implant valve 1 coincides with the beginning of the rigid shell 9 , so that the blood can flow easily into the implant valve 1 .
- the flexible, tubular valve body 10 is pulled taut, so that blood can flow through the implant valve 1 , with little flow resistance in the direction of the arrow 11 , to the exit outflow opening 14 of the valve.
- the flexible tube 3 is preferably substantially cylindrical, or diverging so that an orifice can be achieved whose opening increases or is as constant as possible.
- the outflow opening 14 can be slightly smaller than the inflow opening 12 .
- the flexible, tubular valve body 10 When, during a period between two systoles of the muscle pump, the blood tends to flow in the opposite direction of the blood circulation, i.e. in the direction of the arrow 13 , for instance under the influence of gravity, the flexible, tubular valve body 10 will collapse ( FIG. 2B ).
- the flexible, tubular valve body 10 is insufficiently rigid to keep the outflow opening 14 open.
- the flexible, tubular valve body 10 will collapse and cover the flow orifice of the rigid shell 9 as a valve and thus impede the flow through the valve body 1 .
- the flexible, tubular valve body 10 Upon a subsequent systole, the flexible, tubular valve body 10 will be stretched again as a result of a flow in the direction of the blood circulation. Since the flexible tubular valve body 10 in each case virtually abuts the inner wall of the blood vessel 2 to subsequently collapse, it is avoided that blood can reside between the tubular valve body 10 and the inner wall 2 A of the blood vessel 2 for a long time.
- the ratio of the length of the part l to the part k is in the interval of 1:2 tot 2:1.
- the length of the part l is less than or equal to the length of the part k.
- the support 4 can be provided with support means extending in the direction of the longitudinal axis A.
- the support means support the inner wall 3 A along a part P of the circumference over at least a part of the length F of the second part k of the tube 3 , corresponding to the flexible, tubular valve body 10 .
- the support means are designed as a finger-shaped extension 17 of the casing 5 of the support 4 .
- two finger-shaped extensions 17 situated opposite each other can be provided, or three finger-shaped extensions 17 interspaced along the circumference of the casing 5 .
- FIG. 3 there is shown a second embodiment of the implant valve 1 .
- the tube 3 is folded double so that the inner wall 3 A of the tube 3 , from the outer surface 5 A of the casing 5 , while forming the flexible tubular valve body 10 , extends along the inner surface 5 B of the casing of the support 4 .
- the support 4 along its inner casing 5 B, can be smoothly covered, which facilitates the circulation through the valve and decreases the chance of blood clotting.
- the ends 20 , 21 of the tube 3 are connected to form a ring around the support. Hence, the tube 3 is connected around the support 4 .
- the ends 20 , 21 of the tube 3 are pushed against the inner wall 2 A of the blood vessel 2 and no blood flows around them.
- the entire surface of the implant valve 1 around which, in implanted condition, blood flows, can be smooth, so that the flow resistance of the implant valve 1 is further reduced and the chance of blood clotting is further reduced.
- the implant valve is manufactured from a substantially cylindrical part of a vein.
- the outer surface 3 B of the tube 3 is formed by endothelial cells.
- an implant valve 1 is obtained with a very low flow resistance in the direction of the blood stream and a very small chance of it causing blood clotting.
- the implant valve 1 is manufactured from a part of a body specific vein.
- a substantially cylindrical part of a vein situated near the surface of the body can be removed to be subsequently applied as a flexible tube 3 for an implant valve 1 which is implanted in a deeper vein.
- a part of a vein situated near the surface of the lower leg can be removed to be subsequently applied as a flexible tube in an implant valve which is implanted in a deeper vein in the lower leg of that patient.
- the implant valve 1 can be manufactured by positioning the support 4 with its inner casing 5 B around the outer wall 3 B of the tube-shaped part 3 , and turning the tube-shaped part 3 inside out by folding the ends 20 , 21 of the tube part along the outer casing 5 A of the support 4 , and connecting the ends to each other, thus forming a flexible, tubular valve body 10 axially contiguous to the support 4 .
- the ends 20 , 21 of the tube can be connected to each other in a surgical manner known per se, for instance by stitches 18 . In such a manner, the inner surface 3 A of the tube 3 , i.e.
- the original outer surface of the vein can be connected to the outer and inner surface 5 A, 5 B of the casing 5 , respectively, such that the tube 3 , in implantation position II of the support 4 , is positioned tightly along the outer surface 5 A of the casing 5 .
- the tube 3 in implantation position II of the support 4 , is positioned tightly along the outer surface 5 A of the casing 5 .
- the implant valve 1 can be implanted by positioning the implant valve 1 with the support 4 in initial position I in a blood vessel and transporting it, with the aid of a transport device, through the vein to an implantation site ( FIG. 4 ).
- An example of this is the percutaneous or minimally invasive insertion of the implant valve in a vein at the location of the groin 26 of a person and, after possible removal of badly functioning valves present in the vein 26 , transporting the implant valve 1 through the vein 26 to a part of that vein which forms the location of implantation 28 , situated just below or over the knee 27 .
- the implant valve 1 can then be fixed by bringing support 4 into the implantation position II, so that a first part of the tube is clamped as a rigid shell 9 substantially coaxially along the inner wall 27 A of the vein 27 , while a second part of the tube 3 , contiguous in the direction of the axis A, forms a flexible, tubular valve body, extending substantially clear in the vein.
- the flexible, tubular valve body 10 is then, for instance, viewed from the groin 26 , situated before the rigid shell-shaped part 9 , so that a downward flow through the valve body 10 against the blood circulation, resulting from gravity, is avoided, while an upward flow as a result of the systole of the heart in the direction of the blood circulation is obstructed as little as possible.
- a balloon catheter 30 can be used as a transport device.
- the implant valve, with the support 4 in initial position I, is then fitted coaxially around the balloon 31 of the balloon catheter 30 .
- the implant valve can be fixed at the implantation location 28 by expanding the balloon 3 , thus bringing the support 4 into the implantation position II. After shrinkage of the balloon 3 , the balloon catheter 30 can subsequently, while leaving the implant valve 1 behind, be recovered. Balloon catheters and the manner of operation thereof are known to the skilled person and will not be further elucidated here.
- an implant valve can be equipped with a support of the “Self-expandable” type, in which the support is kept in the initial position by fitting the implant valve into a sleeve.
- the transport device can then be formed by a sleeve which, with the aid of a coaxial cable, can be inserted and where, by displacing the cables relative to each other, the implant valve can be pushed from the container, after which it expands itself.
- the flexible tube and/or the support can be manufactured from biocompatible plastic material.
- the support means, in particular the finger-shaped extensions can be provided with a protective layer or can be made of a somewhat flexible design to reduce the chance of damage to the flexible tube during use and to increase durability of the implant valve.
Abstract
An implant valve for implantation in a blood vessel is comprised of a flexible tube and a hollow, substantially cylindrical support with a casing, expandable in diameter from an initial position to an implantation position. The support extends substantially coaxially over a part of the length of the tube along the inner wall of the tube. The casing of the support cooperates with the inner wall of the tube such that, in the implantation position, a first part of the tube can be formed into a rigid shell, which can be clamped substantially coaxially along the inner wall of a blood vessel. A second, axially contiguous part of the tube can then form a flexible, tubular valve body, which can extend substantially clear in the blood vessel. In an advantageous embodiment, the flexible tube comprises a vein turned inside out and the ends of the tube are connected to form a ring embracing the support.
Description
- The invention relates to an implant valve for implantation in a blood vessel.
- Such implant valves are known and are applied for regulating the blood circulation through a vascular system, such as the human vascular system.
- The vascular system, in particular the venous vascular system in legs and arms, is, at certain locations, provided with bag-shaped valves, also called “cusps”. The function of the valves is to impede the blood flowing against the direction of the blood circulation through the vascular system. In particular, this function is important in the period of relatively low blood pressure in the vascular system, occurring between systoles of the heart.
- In some cases, however, the valves in the vessels of the vascular system do not close properly, so that blood can flow through the valves against the blood circulation. This problem especially occurs when the valves are damaged as a result of blood clots (thrombosis). Further, the closing action of the valves or cusps can be lost due to the diameter of veins increasing, for instance when the elasticity of the veins decreases.
- When the blocking action of the valves is insufficient, the chance exists that the blood circulates insufficiently through the vascular system and that accumulation of blood occurs at a particular point. In particular in lower body extremities such as the ankles, under the influence of gravity, this can cause an increased venous blood pressure, which can lead to a further dilatation of the venous system and, in veins which are located at the surface of the body, even to seriously dilated blood vessels and, eventually, to skin defects (ulcers).
- In order to counteract these problems, it is known to fit implant valves with artificially formed bag-shaped valves in the veins. To avoid surgical intervention as much as possible, it has already been proposed to introduce the implant valve into a vein at an easily accessible location, for instance, at the location of the groin, and to transport the implant valve with the aid of an inserter through the vein to a desired location, for instance at the location of the lower leg just under of above the knee, and there to fix the implant valve in the vein by expansion. An implant valve with an expandable support provided with bag-shaped valves and a method for percutaneously fitting such an implant valve in a vein are known from NL 1004827.
- A drawback of the known implant valve is that it, in itself, increases the chance of clotting of blood or thrombosis considerably. In particular, the chance exists that in the flow direction, directly behind the bag-shaped valve body near the location where it abuts the wall of the vein, clotting of blood occurs through insufficient circulation. Further, the known valve body is provided with a relatively rough and irregular surface, which increases the chance of clotting through adhesion. Also, the flow resistance in the direction of the blood circulation is not optimally low.
- Further, the known valve is difficult to manufacture because of its complex construction. In particular, the manufacture of the valve body from body specific material is a problem.
- Additionally, because of the relatively complex construction of the implant valve, it has proved to be a problem to design it with a sufficiently small diameter to move it to body extremities such as forearms or lower legs.
- The object of the invention is an implant valve which does not have the above-mentioned drawbacks. To that end, the invention provides an implant valve for implantation in a blood vessel, comprising a flexible tube and a hollow, substantially cylindrical support with a casing which is expandable in diameter from an initial position into an implantation position, the support extending over a part of the length of the tube substantially coaxially along the inner wall of the tube and the casing of the support cooperating with the inner wall of the tube such that, in the implantation position of the support, a first part of the tube can be formed to be a rigid shell which can be clamped substantially coaxially along the inner wall of a blood vessel, while a second, axially contiguous part of the tube can form a flexible, tubular valve body which can extend substantially free in the blood vessel.
- Thus, it is achieved that the valve has a simple construction, so that it can be relatively easily manufactured with a small diameter. Further, the flexible tube of the valve can relatively easily be designed from body specific material. Additionally, the valve has a relatively low flow resistance, in particular when a substantially cylindrical flexible tube is applied, and when blood flows through it in the direction of the blood circulation from the rigid, tubular part, while circulation in the opposite direction through deformation of the tubular flexible valve body is effectively counteracted. Further, it is achieved that the chance of blood clotting as a result of the valve can be considerably reduced.
- Further advantageous embodiments of the invention are described in the subclaims. The invention further relates to a method for implanting an implant valve and to a method for manufacturing an implant valve.
- It is noted that in this context, for brevity's sake, an implant valve is also referred to as valve. The invention will be further elucidated on the basis of an exemplary embodiment, represented in a drawing.
- In the drawing:
-
FIG. 1 shows a schematic, partly sectional perspective view of a first embodiment of the implant valve; -
FIG. 1A shows a schematic perspective view of a support in initial position; -
FIG. 1B shows a schematic perspective view of a support in implantation position; -
FIG. 2A shows a schematic perspective view of the implant valve ofFIG. 1 in implanted condition during a systole of the muscle pump; -
FIG. 2B shows the implant valve ofFIG. 2A in the diastolic phase between two systoles of the muscle pump; -
FIG. 3 shows a schematic cross section of a second embodiment of the implant valve; -
FIG. 4 shows a schematic representation of the implantation of the implant valve with the aid of a transport device. - It is noted that the Figures are only schematic representations of preferred embodiments of the invention. In the Figures, identical or corresponding parts are designated by the same reference numerals.
- Referring to
FIGS. 1 and 2 , there is shown animplant valve 1 for implantation in ablood vessel 2. Theimplant valve 1 comprises aflexible tube 3 and a hollow, substantially cylindrical support 4. Thetube 3 is manufactured from biocompatible material, preferably body specific material. The support 4 has acasing 5, expandable in diameter from an initial position I to an implantation position II.FIG. 1A shows the support 4 in the initial position I andFIG. 1B shows the support 4 in the implantation position II. From the initial position I, the support 4 expands over its entire length l in radial direction in relation to its longitudinal axis A, such that the diameter of thecasing 5 of the support 4 increases from a first value D1 to a greater value D2. It is noted that, normally, the length l then decreases to a value l′. - The
casing 5 of support 4 is preferably built up from an interlacement of two cylindrically interwoven, zigzagging,biocompatible metal wires 6. The interlacement can be designed to be pushed, with the aid of a balloon catheter, from the initial position I into the implantation position II (Balloon extendable type), but can also be designed from memory metal which, upon expansion, unfolds itself from the initial condition into the implantation condition II (Self expandable type). Such supports are usually referred to as “stents”, and, since they are generally known, will not be further elucidated here. - The support 4 extends over a part l of the length L of the
tube 3. Thecasing 5 of the support 4 is connected to theinner wall 3A of thetube 3, for instance in that thewires 6 of thecasing 5 of the support 4 are sewn to thetube 3, such that theinner wall 3A, in the implantation position I, loosely envelops theouter casing surface 5A of the support 4. Theouter surface 5A of thecasing 5 cooperates with theinner wall 3A of thetube 3 such that, in the implantation position, theinner wall 3A is pulled taut by theouter surface 5A of the support to form arigid shell 9. Therigid shell 9 extends over a first part l of the length L of thetube 3. A second part of thetube 3 contiguous thereto in axial direction A is not supported by the support 4 and forms a flexible,tubular valve body 10. - In implanted condition in a
blood vessel 2, therigid shell 9 extends substantially coaxially along the inner wall 2A of the blood vessel, and theouter wall 3B of thetube 3 is clamped by the support 4 in implantation position II, in a tubular shape, against the inner wall 2A of theblood vessel 2. The second part of thetube 3 contiguous thereto in axial direction forms a flexible,tubular valve body 10 extending over a part k of the length L of the tube, extending substantially clear in theblood vessel 2. In particular, theouter wall 3B of thetube 3 is then substantially clear of the inner wall 2A of theblood vessel 2. - In implanted condition, blood can pass in the direction of the arrow 11 in the direction of the blood circulation through the
implant valve 1, for instance upon a systole of the muscle pump. Theinflow opening 12 of theimplant valve 1 coincides with the beginning of therigid shell 9, so that the blood can flow easily into theimplant valve 1. Subsequently, the flexible,tubular valve body 10, as a result of the flow of the blood in the direction of the arrow 11, is pulled taut, so that blood can flow through theimplant valve 1, with little flow resistance in the direction of the arrow 11, to theexit outflow opening 14 of the valve. - The
flexible tube 3 is preferably substantially cylindrical, or diverging so that an orifice can be achieved whose opening increases or is as constant as possible. In practice, with acylindrical tube 3, theoutflow opening 14 can be slightly smaller than theinflow opening 12. - When, during a period between two systoles of the muscle pump, the blood tends to flow in the opposite direction of the blood circulation, i.e. in the direction of the
arrow 13, for instance under the influence of gravity, the flexible,tubular valve body 10 will collapse (FIG. 2B ). The flexible,tubular valve body 10 is insufficiently rigid to keep theoutflow opening 14 open. Already under the influence of an initial flow against the blood circulation in the direction of thearrow 13, the flexible,tubular valve body 10 will collapse and cover the flow orifice of therigid shell 9 as a valve and thus impede the flow through thevalve body 1. - Upon a subsequent systole, the flexible,
tubular valve body 10 will be stretched again as a result of a flow in the direction of the blood circulation. Since the flexibletubular valve body 10 in each case virtually abuts the inner wall of theblood vessel 2 to subsequently collapse, it is avoided that blood can reside between thetubular valve body 10 and the inner wall 2A of theblood vessel 2 for a long time. - Preferably, the ratio of the length of the part l to the part k is in the interval of 1:2 tot 2:1. Advantageously, the length of the part l is less than or equal to the length of the part k.
- To prevent that the
valve body 10, under the influence of a flow in the direction of thearrow 13, folds back into the passage of therigid shell 9, and allows a renewed flow in the direction of thearrow 13, the support 4 can be provided with support means extending in the direction of the longitudinal axis A. The support means support theinner wall 3A along a part P of the circumference over at least a part of the length F of the second part k of thetube 3, corresponding to the flexible,tubular valve body 10. In the embodiment shown inFIGS. 1-2 , the support means are designed as a finger-shapedextension 17 of thecasing 5 of the support 4. Also, instead of one finger-shapedextension 17, for instance, two finger-shapedextensions 17, situated opposite each other can be provided, or three finger-shapedextensions 17 interspaced along the circumference of thecasing 5. - Referring to
FIG. 3 , there is shown a second embodiment of theimplant valve 1. In this embodiment, thetube 3 is folded double so that theinner wall 3A of thetube 3, from theouter surface 5A of thecasing 5, while forming the flexibletubular valve body 10, extends along theinner surface 5B of the casing of the support 4. Thus, it is achieved that the support 4, along itsinner casing 5B, can be smoothly covered, which facilitates the circulation through the valve and decreases the chance of blood clotting. - The ends 20, 21 of the
tube 3 are connected to form a ring around the support. Hence, thetube 3 is connected around the support 4. By placing the connected outer ends 20, 21 of thetube 3 at theouter surface 5B of thecasing 5, it is achieved that the ends 20, 21 of theimplant valve 1, in implanted condition, are pushed against the inner wall 2A of theblood vessel 2 and no blood flows around them. Thus, the entire surface of theimplant valve 1, around which, in implanted condition, blood flows, can be smooth, so that the flow resistance of theimplant valve 1 is further reduced and the chance of blood clotting is further reduced. - In an advantageous manner, the implant valve is manufactured from a substantially cylindrical part of a vein. By turning the vein inside out, it can be achieved that the
outer surface 3B of thetube 3 is formed by endothelial cells. In particular when the outer ends 20, 21 of the vein, turned inside out, are connected in a ring-shape and the outer ends 20, 21 are situated at theouter surface 5B of thecasing 5, as is described hereinabove, animplant valve 1 is obtained with a very low flow resistance in the direction of the blood stream and a very small chance of it causing blood clotting. - Preferably, the
implant valve 1 is manufactured from a part of a body specific vein. For instance, from a patient, a substantially cylindrical part of a vein situated near the surface of the body, can be removed to be subsequently applied as aflexible tube 3 for animplant valve 1 which is implanted in a deeper vein. Thus, from a patient suffering from thrombosis, a part of a vein situated near the surface of the lower leg can be removed to be subsequently applied as a flexible tube in an implant valve which is implanted in a deeper vein in the lower leg of that patient. - The
implant valve 1 can be manufactured by positioning the support 4 with itsinner casing 5B around theouter wall 3B of the tube-shapedpart 3, and turning the tube-shapedpart 3 inside out by folding the ends 20, 21 of the tube part along theouter casing 5A of the support 4, and connecting the ends to each other, thus forming a flexible,tubular valve body 10 axially contiguous to the support 4. The ends 20, 21 of the tube can be connected to each other in a surgical manner known per se, for instance by stitches 18. In such a manner, theinner surface 3A of thetube 3, i.e. the original outer surface of the vein, can be connected to the outer andinner surface casing 5, respectively, such that thetube 3, in implantation position II of the support 4, is positioned tightly along theouter surface 5A of thecasing 5. In this manner, it can be achieved that only the layer of the tubular part of the vein covered in endothelium can contact the blood, while the support and anysupport parts 17 connected thereto are covered and protected from the blood. - The
implant valve 1 can be implanted by positioning theimplant valve 1 with the support 4 in initial position I in a blood vessel and transporting it, with the aid of a transport device, through the vein to an implantation site (FIG. 4 ). An example of this is the percutaneous or minimally invasive insertion of the implant valve in a vein at the location of thegroin 26 of a person and, after possible removal of badly functioning valves present in thevein 26, transporting theimplant valve 1 through thevein 26 to a part of that vein which forms the location ofimplantation 28, situated just below or over theknee 27. Theimplant valve 1 can then be fixed by bringing support 4 into the implantation position II, so that a first part of the tube is clamped as arigid shell 9 substantially coaxially along theinner wall 27A of thevein 27, while a second part of thetube 3, contiguous in the direction of the axis A, forms a flexible, tubular valve body, extending substantially clear in the vein. The flexible,tubular valve body 10 is then, for instance, viewed from thegroin 26, situated before the rigid shell-shapedpart 9, so that a downward flow through thevalve body 10 against the blood circulation, resulting from gravity, is avoided, while an upward flow as a result of the systole of the heart in the direction of the blood circulation is obstructed as little as possible. - Preferably, as a transport device, a
balloon catheter 30 can be used. The implant valve, with the support 4 in initial position I, is then fitted coaxially around theballoon 31 of theballoon catheter 30. The implant valve can be fixed at theimplantation location 28 by expanding theballoon 3, thus bringing the support 4 into the implantation position II. After shrinkage of theballoon 3, theballoon catheter 30 can subsequently, while leaving theimplant valve 1 behind, be recovered. Balloon catheters and the manner of operation thereof are known to the skilled person and will not be further elucidated here. - It is also possible to use different types of transport devices. For instance, an implant valve can be equipped with a support of the “Self-expandable” type, in which the support is kept in the initial position by fitting the implant valve into a sleeve. The transport device can then be formed by a sleeve which, with the aid of a coaxial cable, can be inserted and where, by displacing the cables relative to each other, the implant valve can be pushed from the container, after which it expands itself.
- It will be clear that the invention is not limited to the preferred embodiments discussed here, but that many variations are possible. In particular, the flexible tube and/or the support can be manufactured from biocompatible plastic material. Also, the support means, in particular the finger-shaped extensions, can be provided with a protective layer or can be made of a somewhat flexible design to reduce the chance of damage to the flexible tube during use and to increase durability of the implant valve.
- Such variants are understood to fall within the scope of the invention as set forth in the following claims.
Claims (11)
1. An implant valve for implantation in a blood vessel, comprising a flexible tube and a hollows, substantially cylindrical support with a casing which is expandable in diameter from an initial position into an implantation position, the support extending over a part of the length of the tube substantially coaxially along the wall of the tube, the casing of the support cooperating with the wall of the tube and, in the implantation position, forming a first part of the tube into a rigid shell which, in use, is clamped substantially coaxially along the inner wall of a blood vessel, while a second, axially contiguous part of the tube forms a flexible tubular valve body, which in use extends substantially clear in the blood vessel, characterized in that the casing of the support cooperates with the inner wall of the tube and in that the support is provided with axially extending support means for supporting, along a part of its circumference, the inner wall of the second part of the tube of the flexible, tubular valve body formed in the implantation position.
2. An implant valve according to claim 1 , wherein the support means comprise a finger-shaped extension of the casing of the support.
3. An implant valve according to claim 2 , wherein the support means comprise two or three finger-shaped extensions interspaced along the circumference of the casing.
4. An implant valve according to claim 1 , wherein the tube is folded double so that the inner wall of the tube extends from the outer surface of the casing while forming the second tube part to the inner surface of the casing of the support.
5. An implant valve according to claim 4 , wherein the ends of the tube are connected to form a ring surrounding the support.
6. An implant valve according to claim 5 , wherein the connected ends of the tube are situated at the outer surface of the casing.
7. An implant valve according to claim 6 , wherein the tube comprises a part of a vein which has been turned inside out, such that the endothelium of the vein forms the outer surface of the tube.
8. A support, such as a stent, comprising a hollow, substantially cylindrical support with a casing expandable in diameter from an initial position to an implantation position, the support being provided with axially extending support means comprising a finger-shaped extension of the casing of the support.
9. A method for implanting an implant valve according to claim 1 , wherein the implant valve, with the support in initial position, is placed in a blood vessel and wherein the implant valve, with the aid of a transport device, is transported through the blood vessel to a location of implantation, wherein, subsequently, the diameter of the casing of the support is brought into the implantation position, so that a first part of the tube is clamped as a rigid shell, substantially coaxially along the inner wall of the blood vessel, and a second, axially contiguous part of the tube forms a flexible tubular valve body extending substantially clear in the blood vessel.
10. A method for manufacturing an implant valve for implantation in a blood vessel, preferably an implant valve according to claim 7 , from a tubular part of a vein and a hollow, substantially cylindrical support with a casing expandable in diameter from an initial position to an implantation position, wherein the part of the vein is turned inside out and wherein the ends of the tube are connected to form a ring embracing the support, and wherein the original outer wall, while forming a flexible, tubular valve body, axially contiguous to the support, is connected to the inner surface and the outer surface of the casing.
11. A method for manufacturing an implant valve for implantation in a blood vessel, preferably an implant valve according to claim 8 , from a tubular part of a vein and a hollow, substantially cylindrical support with a casing expandable in diameter from an initial position to an implantation position, wherein the part of the vein is turned inside out and wherein the ends of the tube are connected to form a ring embracing the support, and wherein the original outer wall, while forming a flexible, tubular valve body, axially contiguous to the support, is connected to the inner surface and the outer surface of the casing.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US12/807,405 US20110004295A1 (en) | 2000-01-17 | 2010-09-03 | Implant valve for implantation in a blood vessel |
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
NL1014095A NL1014095C2 (en) | 2000-01-17 | 2000-01-17 | Implant valve for implantation into a blood vessel. |
NLNL1014095 | 2000-01-17 | ||
PCT/NL2001/000027 WO2001052775A1 (en) | 2000-01-17 | 2001-01-16 | Implant valve for implantation in a blood vessel |
US10/181,703 US7811315B2 (en) | 2000-01-17 | 2001-01-16 | Implant valve for implantation in a blood vessel |
US12/807,405 US20110004295A1 (en) | 2000-01-17 | 2010-09-03 | Implant valve for implantation in a blood vessel |
Related Parent Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US10/181,703 Continuation US7811315B2 (en) | 2000-01-17 | 2001-01-16 | Implant valve for implantation in a blood vessel |
PCT/NL2001/000027 Continuation WO2001052775A1 (en) | 2000-01-17 | 2001-01-16 | Implant valve for implantation in a blood vessel |
Publications (1)
Publication Number | Publication Date |
---|---|
US20110004295A1 true US20110004295A1 (en) | 2011-01-06 |
Family
ID=19770610
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US10/181,703 Expired - Fee Related US7811315B2 (en) | 2000-01-17 | 2001-01-16 | Implant valve for implantation in a blood vessel |
US12/807,405 Abandoned US20110004295A1 (en) | 2000-01-17 | 2010-09-03 | Implant valve for implantation in a blood vessel |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US10/181,703 Expired - Fee Related US7811315B2 (en) | 2000-01-17 | 2001-01-16 | Implant valve for implantation in a blood vessel |
Country Status (8)
Country | Link |
---|---|
US (2) | US7811315B2 (en) |
EP (1) | EP1248579B1 (en) |
AT (1) | ATE484261T1 (en) |
AU (1) | AU2001234225A1 (en) |
DE (1) | DE60143251D1 (en) |
ES (1) | ES2356198T3 (en) |
NL (1) | NL1014095C2 (en) |
WO (1) | WO2001052775A1 (en) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20100256776A1 (en) * | 2005-01-19 | 2010-10-07 | Gi Dynamics, Inc. | Eversion Resistant Sleeves |
US20140005766A1 (en) * | 2002-01-04 | 2014-01-02 | Colibri Heart Valve Llc | Percutaneously implantable replacement heart valve device and method of making same |
US20170156863A1 (en) * | 2015-12-03 | 2017-06-08 | Medtronic Vascular, Inc. | Venous valve prostheses |
US9737400B2 (en) | 2010-12-14 | 2017-08-22 | Colibri Heart Valve Llc | Percutaneously deliverable heart valve including folded membrane cusps with integral leaflets |
Families Citing this family (61)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6454799B1 (en) | 2000-04-06 | 2002-09-24 | Edwards Lifesciences Corporation | Minimally-invasive heart valves and methods of use |
US8038708B2 (en) * | 2001-02-05 | 2011-10-18 | Cook Medical Technologies Llc | Implantable device with remodelable material and covering material |
US6733525B2 (en) | 2001-03-23 | 2004-05-11 | Edwards Lifesciences Corporation | Rolled minimally-invasive heart valves and methods of use |
US20030050648A1 (en) | 2001-09-11 | 2003-03-13 | Spiration, Inc. | Removable lung reduction devices, systems, and methods |
US6893460B2 (en) | 2001-10-11 | 2005-05-17 | Percutaneous Valve Technologies Inc. | Implantable prosthetic valve |
US6592594B2 (en) | 2001-10-25 | 2003-07-15 | Spiration, Inc. | Bronchial obstruction device deployment system and method |
US20030181922A1 (en) | 2002-03-20 | 2003-09-25 | Spiration, Inc. | Removable anchored lung volume reduction devices and methods |
US20030216769A1 (en) | 2002-05-17 | 2003-11-20 | Dillard David H. | Removable anchored lung volume reduction devices and methods |
EP1659992B1 (en) * | 2003-07-31 | 2013-03-27 | Cook Medical Technologies LLC | Prosthetic valve devices and methods of making such devices |
US7533671B2 (en) | 2003-08-08 | 2009-05-19 | Spiration, Inc. | Bronchoscopic repair of air leaks in a lung |
US9579194B2 (en) | 2003-10-06 | 2017-02-28 | Medtronic ATS Medical, Inc. | Anchoring structure with concave landing zone |
US20050096738A1 (en) * | 2003-10-06 | 2005-05-05 | Cali Douglas S. | Minimally invasive valve replacement system |
US20060259137A1 (en) * | 2003-10-06 | 2006-11-16 | Jason Artof | Minimally invasive valve replacement system |
WO2005096988A1 (en) | 2004-04-01 | 2005-10-20 | Cook Incorporated | A device for retracting the walls of a body vessel with remodelable material |
EP1737390A1 (en) * | 2004-04-08 | 2007-01-03 | Cook Incorporated | Implantable medical device with optimized shape |
US20080221669A1 (en) * | 2005-07-27 | 2008-09-11 | Sango S.A.S Di Cattani Rita E C. | Endovenous Stent and Venous Neovalvular Endobioprosthesis |
WO2007016122A2 (en) * | 2005-07-27 | 2007-02-08 | Cook Incorporated | Implantable remodelable materials comprising magnetic material |
WO2007016251A2 (en) * | 2005-07-28 | 2007-02-08 | Cook Incorporated | Implantable thromboresistant valve |
US20070027528A1 (en) * | 2005-07-29 | 2007-02-01 | Cook Incorporated | Elliptical implantable device |
US7691151B2 (en) | 2006-03-31 | 2010-04-06 | Spiration, Inc. | Articulable Anchor |
EP2641572B1 (en) | 2007-10-12 | 2019-07-24 | Spiration Inc. | Valve loader method, system, and apparatus |
US7846199B2 (en) * | 2007-11-19 | 2010-12-07 | Cook Incorporated | Remodelable prosthetic valve |
US8870950B2 (en) | 2009-12-08 | 2014-10-28 | Mitral Tech Ltd. | Rotation-based anchoring of an implant |
WO2011111047A2 (en) | 2010-03-10 | 2011-09-15 | Mitraltech Ltd. | Prosthetic mitral valve with tissue anchors |
US8579964B2 (en) | 2010-05-05 | 2013-11-12 | Neovasc Inc. | Transcatheter mitral valve prosthesis |
US9763657B2 (en) | 2010-07-21 | 2017-09-19 | Mitraltech Ltd. | Techniques for percutaneous mitral valve replacement and sealing |
US11653910B2 (en) | 2010-07-21 | 2023-05-23 | Cardiovalve Ltd. | Helical anchor implantation |
US9308087B2 (en) | 2011-04-28 | 2016-04-12 | Neovasc Tiara Inc. | Sequentially deployed transcatheter mitral valve prosthesis |
US9554897B2 (en) | 2011-04-28 | 2017-01-31 | Neovasc Tiara Inc. | Methods and apparatus for engaging a valve prosthesis with tissue |
US8852272B2 (en) | 2011-08-05 | 2014-10-07 | Mitraltech Ltd. | Techniques for percutaneous mitral valve replacement and sealing |
EP3417813B1 (en) | 2011-08-05 | 2020-05-13 | Cardiovalve Ltd | Percutaneous mitral valve replacement |
US20140324164A1 (en) * | 2011-08-05 | 2014-10-30 | Mitraltech Ltd. | Techniques for percutaneous mitral valve replacement and sealing |
WO2013021374A2 (en) | 2011-08-05 | 2013-02-14 | Mitraltech Ltd. | Techniques for percutaneous mitral valve replacement and sealing |
US9345573B2 (en) | 2012-05-30 | 2016-05-24 | Neovasc Tiara Inc. | Methods and apparatus for loading a prosthesis onto a delivery system |
US20150351906A1 (en) | 2013-01-24 | 2015-12-10 | Mitraltech Ltd. | Ventricularly-anchored prosthetic valves |
EP2809264A4 (en) * | 2013-03-01 | 2015-09-09 | Cormatrix Cardiovascular Inc | Two-piece prosthetic valve |
US9572665B2 (en) | 2013-04-04 | 2017-02-21 | Neovasc Tiara Inc. | Methods and apparatus for delivering a prosthetic valve to a beating heart |
JP6561044B2 (en) | 2013-05-03 | 2019-08-14 | メドトロニック,インコーポレイテッド | Valve transfer tool |
EP2918247A1 (en) * | 2014-03-11 | 2015-09-16 | Epygon Sasu | A prosthetic valve and a delivery device |
EP4066786A1 (en) | 2014-07-30 | 2022-10-05 | Cardiovalve Ltd. | Articulatable prosthetic valve |
US9974651B2 (en) | 2015-02-05 | 2018-05-22 | Mitral Tech Ltd. | Prosthetic valve with axially-sliding frames |
WO2016125160A1 (en) | 2015-02-05 | 2016-08-11 | Mitraltech Ltd. | Prosthetic valve with axially-sliding frames |
US10201425B2 (en) * | 2015-03-02 | 2019-02-12 | Georgia Tech Research Corporation | Implantable open vein valve |
EP3407835A4 (en) | 2016-01-29 | 2019-06-26 | Neovasc Tiara Inc. | Prosthetic valve for avoiding obstruction of outflow |
US10531866B2 (en) | 2016-02-16 | 2020-01-14 | Cardiovalve Ltd. | Techniques for providing a replacement valve and transseptal communication |
GB201613219D0 (en) | 2016-08-01 | 2016-09-14 | Mitraltech Ltd | Minimally-invasive delivery systems |
WO2018029680A1 (en) | 2016-08-10 | 2018-02-15 | Mitraltech Ltd. | Prosthetic valve with concentric frames |
CA3042588A1 (en) | 2016-11-21 | 2018-05-24 | Neovasc Tiara Inc. | Methods and systems for rapid retraction of a transcatheter heart valve delivery system |
US11246704B2 (en) | 2017-08-03 | 2022-02-15 | Cardiovalve Ltd. | Prosthetic heart valve |
US10575948B2 (en) | 2017-08-03 | 2020-03-03 | Cardiovalve Ltd. | Prosthetic heart valve |
US11793633B2 (en) | 2017-08-03 | 2023-10-24 | Cardiovalve Ltd. | Prosthetic heart valve |
US10888421B2 (en) | 2017-09-19 | 2021-01-12 | Cardiovalve Ltd. | Prosthetic heart valve with pouch |
US10537426B2 (en) | 2017-08-03 | 2020-01-21 | Cardiovalve Ltd. | Prosthetic heart valve |
US10856984B2 (en) | 2017-08-25 | 2020-12-08 | Neovasc Tiara Inc. | Sequentially deployed transcatheter mitral valve prosthesis |
GB201720803D0 (en) | 2017-12-13 | 2018-01-24 | Mitraltech Ltd | Prosthetic Valve and delivery tool therefor |
GB201800399D0 (en) | 2018-01-10 | 2018-02-21 | Mitraltech Ltd | Temperature-control during crimping of an implant |
WO2020093172A1 (en) | 2018-11-08 | 2020-05-14 | Neovasc Tiara Inc. | Ventricular deployment of a transcatheter mitral valve prosthesis |
CA3135753C (en) | 2019-04-01 | 2023-10-24 | Neovasc Tiara Inc. | Controllably deployable prosthetic valve |
AU2020271896B2 (en) | 2019-04-10 | 2022-10-13 | Neovasc Tiara Inc. | Prosthetic valve with natural blood flow |
CN114025813A (en) | 2019-05-20 | 2022-02-08 | 内奥瓦斯克迪亚拉公司 | Introducer with hemostatic mechanism |
US11311376B2 (en) | 2019-06-20 | 2022-04-26 | Neovase Tiara Inc. | Low profile prosthetic mitral valve |
Citations (29)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4214587A (en) * | 1979-02-12 | 1980-07-29 | Sakura Chester Y Jr | Anastomosis device and method |
US4265694A (en) * | 1978-12-14 | 1981-05-05 | The United States Of America As Represented By The Department Of Health, Education And Welfare | Method of making unitized three leaflet heart valve |
US4470157A (en) * | 1981-04-27 | 1984-09-11 | Love Jack W | Tricuspid prosthetic tissue heart valve |
US4490859A (en) * | 1982-01-20 | 1985-01-01 | University Of Sheffield | Artificial heart valves |
US4638544A (en) * | 1985-12-09 | 1987-01-27 | General Motors Corporation | Plastic covered fastening device and method of assembly |
US4759758A (en) * | 1984-12-07 | 1988-07-26 | Shlomo Gabbay | Prosthetic heart valve |
US5411552A (en) * | 1990-05-18 | 1995-05-02 | Andersen; Henning R. | Valve prothesis for implantation in the body and a catheter for implanting such valve prothesis |
US5489295A (en) * | 1991-04-11 | 1996-02-06 | Endovascular Technologies, Inc. | Endovascular graft having bifurcation and apparatus and method for deploying the same |
US5522885A (en) * | 1994-05-05 | 1996-06-04 | Autogenics | Assembly tooling for an autologous tissue heart valve |
US5562726A (en) * | 1991-10-25 | 1996-10-08 | Cook Incorporated | Expandable transluminal graft prosthesis for repair of aneurysm and method for implanting |
US5571170A (en) * | 1992-01-08 | 1996-11-05 | Expandable Grafts Partnership | Method and apparatus for bilateral intra-aortic bypass |
US5578017A (en) * | 1995-05-01 | 1996-11-26 | Aguilar; John M. | Enema nozzle with self-adhesive securing means |
US5723003A (en) * | 1994-09-13 | 1998-03-03 | Ultrasonic Sensing And Monitoring Systems | Expandable graft assembly and method of use |
US5755782A (en) * | 1991-01-24 | 1998-05-26 | Autogenics | Stents for autologous tissue heart valve |
US5769887A (en) * | 1994-11-09 | 1998-06-23 | Endotex Interventional Systems, Inc. | Delivery catheter and graft for aneurysm repair |
US5824037A (en) * | 1995-10-03 | 1998-10-20 | Medtronic, Inc. | Modular intraluminal prostheses construction and methods |
US5843158A (en) * | 1996-01-05 | 1998-12-01 | Medtronic, Inc. | Limited expansion endoluminal prostheses and methods for their use |
US5851232A (en) * | 1997-03-15 | 1998-12-22 | Lois; William A. | Venous stent |
US5855601A (en) * | 1996-06-21 | 1999-01-05 | The Trustees Of Columbia University In The City Of New York | Artificial heart valve and method and device for implanting the same |
US5906641A (en) * | 1997-05-27 | 1999-05-25 | Schneider (Usa) Inc | Bifurcated stent graft |
US6010531A (en) * | 1993-02-22 | 2000-01-04 | Heartport, Inc. | Less-invasive devices and methods for cardiac valve surgery |
US6036723A (en) * | 1996-05-02 | 2000-03-14 | B. Braun Celsa | Surgically anastomosable transcutaneous vascular prothesis and set comprising the same |
US6117166A (en) * | 1997-10-27 | 2000-09-12 | Winston; Thomas R. | Apparatus and methods for grafting blood vessel tissue |
US6126686A (en) * | 1996-12-10 | 2000-10-03 | Purdue Research Foundation | Artificial vascular valves |
US20010021872A1 (en) * | 1999-12-31 | 2001-09-13 | Bailey Steven R. | Endoluminal cardiac and venous valve prostheses and methods of manufacture and delivery thereof |
US20010032013A1 (en) * | 1999-11-19 | 2001-10-18 | Denes Marton | Self-supporting laminated films, structural materials and medical devices manufactured therefrom and method of making same |
US20020111665A1 (en) * | 1996-06-20 | 2002-08-15 | Karl-Lutz Lauterjung | Prosthetic repair of body passages |
US20020198594A1 (en) * | 2000-04-06 | 2002-12-26 | Stefan Schreck | Minimally-invasive heart valves and methods of use |
US7081129B2 (en) * | 1998-02-09 | 2006-07-25 | Boston Scientific Santa Rosa Corp. | Endovascular graft |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NL1004827C2 (en) | 1996-12-18 | 1998-06-19 | Surgical Innovations Vof | Device for regulating blood circulation. |
EP0850607A1 (en) * | 1996-12-31 | 1998-07-01 | Cordis Corporation | Valve prosthesis for implantation in body channels |
-
2000
- 2000-01-17 NL NL1014095A patent/NL1014095C2/en not_active IP Right Cessation
-
2001
- 2001-01-16 AT AT01906396T patent/ATE484261T1/en not_active IP Right Cessation
- 2001-01-16 DE DE60143251T patent/DE60143251D1/en not_active Expired - Lifetime
- 2001-01-16 AU AU2001234225A patent/AU2001234225A1/en not_active Abandoned
- 2001-01-16 US US10/181,703 patent/US7811315B2/en not_active Expired - Fee Related
- 2001-01-16 WO PCT/NL2001/000027 patent/WO2001052775A1/en active Application Filing
- 2001-01-16 EP EP01906396A patent/EP1248579B1/en not_active Expired - Lifetime
- 2001-01-16 ES ES01906396T patent/ES2356198T3/en not_active Expired - Lifetime
-
2010
- 2010-09-03 US US12/807,405 patent/US20110004295A1/en not_active Abandoned
Patent Citations (29)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4265694A (en) * | 1978-12-14 | 1981-05-05 | The United States Of America As Represented By The Department Of Health, Education And Welfare | Method of making unitized three leaflet heart valve |
US4214587A (en) * | 1979-02-12 | 1980-07-29 | Sakura Chester Y Jr | Anastomosis device and method |
US4470157A (en) * | 1981-04-27 | 1984-09-11 | Love Jack W | Tricuspid prosthetic tissue heart valve |
US4490859A (en) * | 1982-01-20 | 1985-01-01 | University Of Sheffield | Artificial heart valves |
US4759758A (en) * | 1984-12-07 | 1988-07-26 | Shlomo Gabbay | Prosthetic heart valve |
US4638544A (en) * | 1985-12-09 | 1987-01-27 | General Motors Corporation | Plastic covered fastening device and method of assembly |
US5411552A (en) * | 1990-05-18 | 1995-05-02 | Andersen; Henning R. | Valve prothesis for implantation in the body and a catheter for implanting such valve prothesis |
US5755782A (en) * | 1991-01-24 | 1998-05-26 | Autogenics | Stents for autologous tissue heart valve |
US5489295A (en) * | 1991-04-11 | 1996-02-06 | Endovascular Technologies, Inc. | Endovascular graft having bifurcation and apparatus and method for deploying the same |
US5562726A (en) * | 1991-10-25 | 1996-10-08 | Cook Incorporated | Expandable transluminal graft prosthesis for repair of aneurysm and method for implanting |
US5571170A (en) * | 1992-01-08 | 1996-11-05 | Expandable Grafts Partnership | Method and apparatus for bilateral intra-aortic bypass |
US6010531A (en) * | 1993-02-22 | 2000-01-04 | Heartport, Inc. | Less-invasive devices and methods for cardiac valve surgery |
US5522885A (en) * | 1994-05-05 | 1996-06-04 | Autogenics | Assembly tooling for an autologous tissue heart valve |
US5723003A (en) * | 1994-09-13 | 1998-03-03 | Ultrasonic Sensing And Monitoring Systems | Expandable graft assembly and method of use |
US5769887A (en) * | 1994-11-09 | 1998-06-23 | Endotex Interventional Systems, Inc. | Delivery catheter and graft for aneurysm repair |
US5578017A (en) * | 1995-05-01 | 1996-11-26 | Aguilar; John M. | Enema nozzle with self-adhesive securing means |
US5824037A (en) * | 1995-10-03 | 1998-10-20 | Medtronic, Inc. | Modular intraluminal prostheses construction and methods |
US5843158A (en) * | 1996-01-05 | 1998-12-01 | Medtronic, Inc. | Limited expansion endoluminal prostheses and methods for their use |
US6036723A (en) * | 1996-05-02 | 2000-03-14 | B. Braun Celsa | Surgically anastomosable transcutaneous vascular prothesis and set comprising the same |
US20020111665A1 (en) * | 1996-06-20 | 2002-08-15 | Karl-Lutz Lauterjung | Prosthetic repair of body passages |
US5855601A (en) * | 1996-06-21 | 1999-01-05 | The Trustees Of Columbia University In The City Of New York | Artificial heart valve and method and device for implanting the same |
US6126686A (en) * | 1996-12-10 | 2000-10-03 | Purdue Research Foundation | Artificial vascular valves |
US5851232A (en) * | 1997-03-15 | 1998-12-22 | Lois; William A. | Venous stent |
US5906641A (en) * | 1997-05-27 | 1999-05-25 | Schneider (Usa) Inc | Bifurcated stent graft |
US6117166A (en) * | 1997-10-27 | 2000-09-12 | Winston; Thomas R. | Apparatus and methods for grafting blood vessel tissue |
US7081129B2 (en) * | 1998-02-09 | 2006-07-25 | Boston Scientific Santa Rosa Corp. | Endovascular graft |
US20010032013A1 (en) * | 1999-11-19 | 2001-10-18 | Denes Marton | Self-supporting laminated films, structural materials and medical devices manufactured therefrom and method of making same |
US20010021872A1 (en) * | 1999-12-31 | 2001-09-13 | Bailey Steven R. | Endoluminal cardiac and venous valve prostheses and methods of manufacture and delivery thereof |
US20020198594A1 (en) * | 2000-04-06 | 2002-12-26 | Stefan Schreck | Minimally-invasive heart valves and methods of use |
Cited By (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20140005766A1 (en) * | 2002-01-04 | 2014-01-02 | Colibri Heart Valve Llc | Percutaneously implantable replacement heart valve device and method of making same |
US9554898B2 (en) | 2002-01-04 | 2017-01-31 | Colibri Heart Valve Llc | Percutaneous prosthetic heart valve |
US9610158B2 (en) * | 2002-01-04 | 2017-04-04 | Colibri Heart Valve Llc | Percutaneously implantable replacement heart valve device and method of making same |
US20100256776A1 (en) * | 2005-01-19 | 2010-10-07 | Gi Dynamics, Inc. | Eversion Resistant Sleeves |
US8096966B2 (en) * | 2005-01-19 | 2012-01-17 | Gi Dynamics, Inc. | Eversion resistant sleeves |
US9737400B2 (en) | 2010-12-14 | 2017-08-22 | Colibri Heart Valve Llc | Percutaneously deliverable heart valve including folded membrane cusps with integral leaflets |
US10973632B2 (en) | 2010-12-14 | 2021-04-13 | Colibri Heart Valve Llc | Percutaneously deliverable heart valve including folded membrane cusps with integral leaflets |
US20170156863A1 (en) * | 2015-12-03 | 2017-06-08 | Medtronic Vascular, Inc. | Venous valve prostheses |
US10143554B2 (en) * | 2015-12-03 | 2018-12-04 | Medtronic Vascular, Inc. | Venous valve prostheses |
US10973640B2 (en) | 2015-12-03 | 2021-04-13 | Medtronic Vascular, Inc. | Venous valve prostheses |
US11684476B2 (en) | 2015-12-03 | 2023-06-27 | Medtronic Vascular, Inc. | Venous valve prostheses |
Also Published As
Publication number | Publication date |
---|---|
US20030060875A1 (en) | 2003-03-27 |
ATE484261T1 (en) | 2010-10-15 |
US7811315B2 (en) | 2010-10-12 |
WO2001052775A1 (en) | 2001-07-26 |
AU2001234225A1 (en) | 2001-07-31 |
NL1014095C2 (en) | 2001-07-18 |
EP1248579B1 (en) | 2010-10-13 |
EP1248579A1 (en) | 2002-10-16 |
DE60143251D1 (en) | 2010-11-25 |
ES2356198T3 (en) | 2011-04-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1248579B1 (en) | Implant valve for implantation in a blood vessel | |
JP4148646B2 (en) | Intravascular heart valve surgery device | |
US5562724A (en) | Endovascular graft prosthesis and an implantation method for such a prosthesis | |
US6221091B1 (en) | Coiled sheet valve, filter or occlusive device and methods of use | |
US10098733B2 (en) | Expandable prosthetic valve having anchoring appendages | |
US6098630A (en) | Multiple diameter expandable graft for blood vessel and method for deploying the same | |
US7686844B2 (en) | Prosthetic valve for implantation in a body vessel | |
EP0689806B1 (en) | Implantable tubular prosthesis having cuffs | |
JP5207737B2 (en) | Bifurcated stent with collapsible end | |
KR20070094888A (en) | Method and apparatus for treatment of cardiac valves | |
US20100114305A1 (en) | Implantable Valvular Prosthesis | |
US20100286769A1 (en) | System For Implanting a Valve Prosthesis | |
US20040215339A1 (en) | Venous valve apparatus and method | |
JPH10508775A (en) | Delivery catheters and implants for treating aneurysms | |
JPH05507215A (en) | Fixation device in body cavity | |
CN114555012A (en) | Blow-molded balloon shoulder assembly for transcatheter delivery device | |
CN107616857B (en) | Artificial venous valve | |
AU678331C (en) | An endovascular graft prosthesis and an implantation method for such a prosthesis |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AS | Assignment |
Owner name: WITTENS ADVISORY LTD., CYPRUS Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:WITTENS, CORNELIS HENDRIKUS ANNA;REEL/FRAME:025055/0611 Effective date: 20100910 |
|
AS | Assignment |
Owner name: ANGIODYNAMICS, INC., NEW YORK Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:WITTENS ADVISORY LTD.;REEL/FRAME:025588/0938 Effective date: 20101203 |
|
STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION |